Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The gene p53 encodes a transcriptional activator of genes involved in growth arrest, DNA repair and apoptosis. Loss of p53 function contributes to tumour development in vivo. The transcriptional activation function of p53 is inactivated by interaction with the mdm2 gene product. Amplification of mdm2 has been observed in 36% of human sarcomas, indicating that it may represent an alternative mechanism of preventing p53 function in tumour development. To study mdm2 function in vivo, we generated an mdm2 null allele by homologous recombination. Mdm2 null mice are not viable, and further analysis revealed embryonic lethality around implantation. To examine the importance of the interaction of MDM2 with p53 in vivo, we crossed mice heterozygous for mdm2 and p53 and obtained progeny homozygous for both p53 and mdm2 null alleles. Rescue of the mdm2-/- lethality in a p53 null background suggests that a critical in vivo function of MDM2 is the negative regulation of p53 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mdm2 can recruit HDAC1 to p53 to remove these acetylation marks and allow for p53 ubiquitination and degradation [49] in in vitro and mouse models [47,50].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [50]
In the citing paper
“Loss of Mdm2 leads to cell death by apoptosis and embryonic lethality at the blastocyst stage, and this phenotype is completely rescued by concomitant deletion of p53 (Chavez-Reyes, et al., 2003; Jones, et al., 1995; Montes de Oca Luna, et al., 1995).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Montes de Oca Luna, et al., 1995
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108 and that they exert non-overlapping inhibitory activities towards p53 (Refs 24,109).”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“The crucial importance of MDM2 in regulating p53 was demonstrated using Mdm2-null mice, which display very early embryonic lethality (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
From p53 at a glance (2010) · cites this paper as Montes de Oca Luna et al., 1995
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Research works printed but not linked: 1
- Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris C. C. Cancer Res. 54, 4855–4878 (1994).
Cited by
Items 401–500 of 1,001
The RP-Mdm2-p53 Pathway and Tumorigenesis
Miliani de Marval, P. L., & Zhang, Y. (2011) · Oncotarget · doi:10.18632/oncotarget.228 · Cited by 93
Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis
Wang, J., Thomas, H. R., Li, Z., Yeo, N. C., Scott, H. E., Dang, N. D.-P., Hossain, M. I., Andrabi, S. A., & Parant, J. M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03902-6 · Cited by 102
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 96
“The importance of Mdm2 in appropriately regulating p53 is demonstrated both by the lethality of Mdm2-null mice and the fact that viability can be rescued by simultaneous deletion of the p53 gene (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundUbiquitin, E6-AP, and Their Role in p53 Inactivation
Scheffner, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00003-5 · Cited by 111
Nuclear exclusion of p53 in a subset of tumors requires MDM2 function
Lu, W., Pochampally, R. R., Chen, L., Chomnawang, M. T., Wang, Y., & Chen, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203262 · Cited by 104
“Loss of MDM2 results in embryonic lethality due to activated p53 (Oca Luna et al., 1995; Jones et al., 1995).”
BackgroundThe Regulation of the p53-mediated Stress Response by MDM2 and MDM4
Perry, M. E. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000968 · Cited by 93
“MDM2 and MDM4 are also required to control p53 function during development, as shown by the early embryonic death of mice lacking either MDM2 or MDM4, unless they also lack p53 (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001; Migliorini et al. 2002).”
BackgroundThe p53 mRNA: an integral part of the cellular stress response
Haronikova, L., Olivares-Illana, V., Wang, L., Karakostis, K., Chen, S., & Fåhraeus, R. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz124 · Cited by 92
The p53 tumor suppressor protein regulates hematopoietic stem cell fate
Asai, T., Liu, Y., Bae, N., & Nimer, S. D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22561 · Cited by 111
“Mice carrying a hypermorphic formof theRad50DNArepair protein exhibit precipitous bone marrow failure due to enhanced signaling through an ATM-Chk2-p53-dependent apoptotic pathway (Bender et al., 2002;Morales et al., 2005).”
BackgroundStructure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation
Zheng, J., Lang, Y., Zhang, Q., Cui, D., Sun, H., Jiang, L., Chen, Z., Zhang, R., Gao, Y., Tian, W., et al. (2015) · Genes & Development · doi:10.1101/gad.261792.115 · Cited by 92
“The negative regulation of p53 byMDM2 has been genetically confirmed, as the early embryonic lethality caused by deletion of theMDM2 gene can be rescued by p53 deletion (Montes de Oca Luna et al. 1995).”
BackgroundDevelopmental Studies of Brca1 and Brca2 Knock-Out Mice
Hakem, R., de la Pompa, J. L., & Mak, T. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018792200700 · Cited by 112
Kurki, S., Latonen, L., & Laiho, M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00714 · Cited by 91
“To address whether PML can affect Mdm2 localization, we ectopically expressed Mdm2 and PML III or PML IV in p53 and mdm2null fibroblasts (Montes de Oca Luna et al., 1995).”
BackgroundMethodApoptotic and Growth-Promoting Activity of E2F Modulated by MDM2
Loughran, Ö., & La Thangue, N. B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2186-2197.2000 · Cited by 91
“Furthermore, mice deficient for mdm2 are not viable unless they lack the p53 gene (23, 33), suggesting that the regulation of p53 is an important physiological function of MDM2.”
BackgroundSmall Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
Zhao, Y., Bernard, D., & Wang, S. (2013) · BioDiscovery · doi:10.7750/biodiscovery.2013.8.4 · Cited by 90
“In approximately half of human cancers, the tumor suppressor function of p53 is inactivated by deletion or mutation of TP53, the gene encoding p53 protein.”
BackgroundInfluentialA Genetic Approach to Mapping the p53 Binding Site in the MDM2 Protein
Freedman, D. A., Epstein, C. B., Roth, J. C., & Levine, A. J. (1997) · Molecular Medicine · doi:10.1007/bf03401678 · Cited by 113
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Argentini, M., Barboule, N., & Wasylyk, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204241 · Cited by 103
“The p53-MDM2 autoregulatory feedback loop is vital, since the early embryonic lethality of mdm2-de®cient mice is rescued in a p53 null background (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundRegulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 102
“The importance of MDM2-regulation of the p53 protein is reflected in the fact that MDM2 deficient mice show a very early embryonic lethality which is entirely rescued when the p53 gene is simultaneously deleted.(22,23) This strongly argues that a crucial function of MDM2, at least during early development, is the regu…”
BackgroundMendrysa, S. M., & Perry, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2023-2030.2000 · Cited by 89
“Second, a lack of mdm2 expression in murine embryos is lethal unless the mice also lack p53, demonstrating that the negative regulation of p53 by MDM2 is critical for normal development (10, 30).”
BackgroundFotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 95
Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?
Costa, D. C. F., de Oliveira, G. A. P., Cino, E. A., Soares, I. N., Rangel, L. P., & Silva, J. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023614 · Cited by 89
“The p53–MDM2 interaction was shown to be critical because the lethality of MDM2-null mice was rescued by the simultaneous deletion of the TP53 gene (Jones et al. 1995; Montes de Oca Luna et al. 1995).”
BackgroundRegulation of p53-MDMX interaction by casein kinase 1 alpha
Chen, L., Li, C., Pan, Y., & Chen, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6509-6520.2005 · Cited by 88
“As expected, the binding between zinc finger deletion mutant (1-300) and p53 was not stimulated by CK1 coexpression (Fig.”
Backgroundp53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Huang, Y., Che, X., Wang, P. W., & Qu, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.001 · Cited by 94
Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
Barboza, J. A., Iwakuma, T., Terzian, T., El-Naggar, A. K., & Lozano, G. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2079 · Cited by 88
“Materials and Methods Mice and Cell Culture Generation of Mdm4 / and Mdm2 / mice was previously described (8, 26).”
BackgroundMethodSelf-citationStrano, S., Rossi, M., Fontemaggi, G., Munarriz, E., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 88
Gannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87
“Studies of Mdm2-mutant mice have highlighted the fundamental importance of Mdm2 in inhibiting p53 stability and function in development (Jones el al., 1995; Montes de Oca Luna et al., 1995; Itahana et al., 2007).”
BackgroundInfluentialAn mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose- and Amino Acid-Deprivation
Ye, P., Liu, Y., Chen, C., Tang, F., Wu, Q., Wang, X., Liu, C.-G., Liu, X., Liu, R., Liu, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.034 · Cited by 96
“Mutation of Mdm2 is lethal before MEFs can be generated (Montes de Oca Luna et al., 1995), but MEFs with an Mdm2 mutation can be produced if Tp53 is also deleted (Montes de Oca Luna et al., 1995).”
BackgroundStommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87
Jones, S. N., Sands, A. T., Hancock, A. R., Vogel, H., Donehower, L. A., Linke, S. P., Wahl, G. M., & Bradley, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14106 · Cited by 87
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
Pedrote, M. M., Motta, M. F., Ferretti, G. D. S., Norberto, D. R., Spohr, T. C. L. S., Lima, F. R. S., Gratton, E., Silva, J. L., & de Oliveira, G. A. P. (2020) · iScience · doi:10.1016/j.isci.2020.100820 · Cited by 83
Migliorini, D., Danovi, D., Colombo, E., Carbone, R., Pelicci, P. G., & Marine, J.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108795200 · Cited by 86
High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas
Valentin-Vega, Y. A., Barboza, J., Chau, G. P., El‐Naggar, A. K., & Lozano, G. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.005 · Cited by 91
“Importantly, this lethal phenotype is completely rescued by loss of p53 [10,11].”
BackgroundSelf-citationThe RING domain of Mdm2 can inhibit cell proliferation.
Dang, J., Kuo, M.-L., Eischen, C. M., Stepanova, L., Sherr, C. J., & Roussel, M. F. (2002) · PubMed · Cited by 99
Krempler, A., Henry, M. D., Triplett, A. A., & Wagner, K.-U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207662200 · Cited by 86
Dysfunction of the MDM2/p53 axis is linked to premature aging
Lessel, D., Wu, D., Trujillo, C., Ramezani, T., Lessel, I., Alwasiyah, M. K., Saha, B., Hisama, F. M., Rading, K., Goebel, I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92171 · Cited by 86
Uterine papillary serous carcinoma evolves via a p53-driven pathway
Moll, U. M., Chalas, E., Auguste, M., Meaney, D., & Chumas, J. C. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90340-8 · Cited by 86
Roles of HAUSP-mediated p53 regulation in central nervous system development
Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P. D., & Gu, W. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.12 · Cited by 79
“Knockout of mdm2 in mice causes embryonic lethality due to p53 activation, whereas knockout of both mdm2 and p53 completely rescues the lethality.(14,15) In addition, the lethality of the knockout mice of mdm4 (murine double minute 4), which encodes an Mdm2related p53-binding protein, can also be rescued by deletion o…”
BackgroundUncovering Ubiquitin and Ubiquitin-like Signaling Networks
Vertegaal, A. C. O. (2011) · Chemical Reviews · doi:10.1021/cr200187e · Cited by 100
Su, W., Fang, J., Cheng, F., Liu, C., Zhou, F., & Zhang, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211604110 · Cited by 92
“The importance of the p53–Mdm2 autoregulatory loop was clearly demonstrated in a study in which the embryonic lethality induced through an Mdm2 deletion was rescued through the simultaneous knocking-out of the p53 gene (5, 6).”
BackgroundSmall molecule agents targeting the p53‐MDM2 pathway for cancer therapy
Wang, W., & Hu, Y. (2012) · Medicinal Research Reviews · doi:10.1002/med.20236 · Cited by 85
“The irrefutable evidence of its essential role in regulating p53 is provided by the fact that specific MDM2-deficient mouse is embryonic lethal, but can be fully rescued by codeficient of p53.(28,29) MDM2 regulates p53 via an auto-regulatory feedback loop in which both proteins maintain low cellular concentrations mut…”
BackgroundProbing p53 biological functions through the use of genetically engineered mouse models
Attardi, L. D., & Donehower, L. A. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.022 · Cited by 97
Tolbert, D., Lu, X., Yin, C., Tantama, M., & Van Dyke, T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.370-377.2002 · Cited by 85
“Mdm2 deficiency in the mouse causes lethality in the early embryo (9, 14), so that a cell-specific deficiency will be required to test the role of Mdm2 in this or any other in vivo tumor model.”
BackgroundTowards an understanding of the role of p53 in adrenocortical carcinogenesis
Wasserman, J. D., Zambetti, G. P., & Malkin, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.010 · Cited by 84
“The embryonic lethality of each null, as well as an MDM2/MDMX double knockout are rescued by a p53 null background (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
Pant, V., Xiong, S., Jackson, J. G., Post, S. M., Abbas, H. A., Quintás-Cardama, A., Hamir, A. N., & Lozano, G. (2013) · Genes & Development · doi:10.1101/gad.227249.113 · Cited by 84
Self-citationValidation of MdmX as a therapeutic target for reactivating p53 in tumors
Garcia, D., Warr, M. R., Martins, C. P., Brown Swigart, L., Passegué, E., & Evan, G. I. (2011) · Genes & Development · doi:10.1101/gad.16722111 · Cited by 83
Targeting p53-MDM2-MDMX Loop for Cancer Therapy
Zhang, Q., Zeng, S. X., & Lu, H. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_16 · Cited by 83
Ubiquitination and Degradation of the Anti-apoptotic Protein ARC by MDM2
Foo, R. S.-Y., Chan, L. K. W., Kitsis, R. N., & Bennett, M. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609046200 · Cited by 83
Léveillard, T., & Wasylyk, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30651 · Cited by 83
Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 93
“This feedback regulation is validated by two gene-targeting studies, which show that depleting the p53 gene rescues the lethality of mdm2 knockout mice [43,44].”
Backgroundp53 Activity Results in DNA Replication Fork Processivity
Klusmann, I., Rodewald, S., Müller, L., Friedrich, M., Wienken, M., Li, Y., Schulz‐Heddergott, R., & Dobbelstein, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.036 · Cited by 86
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
Abbas, R., & Larisch, S. (2021) · Cells · doi:10.3390/cells10123465 · Cited by 95
“This phenotype can be rescued by the inactivation of p53 [147,148].”
BackgroundFortunato, O., Boeri, M., Moro, M., Verri, C., Mensah, M., Conte, D., Caleca, L., Roz, L., Pastorino, U., & Sozzi, G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.507 · Cited by 85
DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms
Li, C., Chen, L., & Chen, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7562-7571.2002 · Cited by 82
“Knockout of MDM2 in mice results in embryonic lethality due to hyperactivation of p53 (11).”
BackgroundTherapeutic targeting of p53 by small molecules
Selivanova, G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.006 · Cited by 93
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Cui, D., Xiong, X., Shu, J., Dai, X., Sun, Y., & Zhao, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.032 · Cited by 81
p53--An Acrobat in Tumorigenesis
Moll, U. M., & Schramm, L. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090010101 · Cited by 93
The role of MDM2 and MDM4 in breast cancer development and prevention
Haupt, S., Vijayakumaran, R., Miranda, P. J., Burgess, A., Lim, E., & Haupt, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx007 · Cited by 85
“…unequivocally demonstrated by the ability of p53 knock-out to rescue the embryonic lethality that results from the loss of either MDM2 (Jones et al., 1995; Montes de Oca Luna et al., 1995) or MDM4 (Parant et al., 2001), as evidenced in mice with independent genetic ablation of each family member.”
BackgroundThe Mdm network and its regulation of p53 activities: a rheostat of cancer risk
Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79
“…Functions of Mdm2 and Mdm4 Critics have used the fact that loss of p53 can rescue the embryonic lethality of Mdm2 or Mdm4 deletion [Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001] to conclude that the sole function of Mdm2 and Mdm4 is to regulate p53.”
BackgroundSelf-citationTRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Zhang, X., Li, C., Zhang, L., Wu, C., Han, L., Jin, G., Rezaeian, A. H., Han, F., Liu, C., Xu, C. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.002 · Cited by 81
“…(Marchenko et al., 2007), such a concept may conflict with well-established genetic evidence that loss of Mdm2 in mice 8 Molecular Cell 64, 1–12, November 17, 2016 causes mouse embryonic lethality through eliciting p53-dependent apoptosis (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundReviving the guardian of the genome: Small molecule activators of p53
Nguyen, D., Liao, W., Zeng, S. X., & Lu, H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.013 · Cited by 79
Sun, X.-X., Wang, Y.-G., Xirodimas, D. P., & Dai, M.-S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098442 · Cited by 80
Mancini, F., Conza, G. D., Pellegrino, M., Rinaldo, C., Prodosmo, A., Giglio, S., D’Agnano, I., Florenzano, F., Felicioni, L., Buttitta, F., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.154 · Cited by 97
“Conversely, the control of p53-apoptotic function has been attributed to MDM2 because of the presence of early embryonic cell death in Mdm2-KO mice (Jones et al, 1995; Montes de Oca-Luna et al, 1995).”
BackgroundRegulation of Apoptosis by Adenovirus E1A and E1B Oncogenes
White, E. P. (1998) · Seminars in Virology · doi:10.1006/smvy.1998.0155 · Cited by 90
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
“Mice lacking either Mdm2 or Mdmx die during embryogenesis, and the embryonic lethality is rescued by p53 deletion (Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001; Migliorini et al., 2002).”
The role of p53 in developmental syndromes
Bowen, M. E., & Attardi, L. D. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy087 · Cited by 86
“5, respectively (Figure 1B and C) (Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001; Chavez-Reyes et al., 2003; Moyer et al., 2017).”
Mechanisms Underlying Recurrent Genomic Amplification in Human Cancers
Tanaka, H., & Watanabe, T. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.019 · Cited by 84
Nie, J., Xie, P., Liu, L., Xing, G., Chang, Z., Yin, Y., Tian, C., He, F., & Zhang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126920 · Cited by 79
Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation
Kulikov, R., Winter, M., & Blattner, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513311200 · Cited by 79
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Zhou, X. Y., Hao, Q., Liao, P., Luo, S., Zhang, M., Hu, G., Liu, H., Zhang, Y.-W., Cao, B., Baddoo, M., et al. (2016) · eLife · doi:10.7554/elife.15099 · Cited by 89
“Genetically, disruption of the TP53 gene completely rescues the lethal phenotype of Mdm2 knockout mice (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis
Ganguli, G., Abecassis, J., & Wasylyk, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5135 · Cited by 82
Meek, D. W., & Hupp, T. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.005 · Cited by 76
Interplay between the tumor suppressor p53 and TGFβ signaling shapes embryonic body axes in Xenopus
Takebayashi-Suzuki, K., Funami, J., Tokumori, D., Saito, A., Watabe, T., Miyazono, K., Kanda, A., & Suzuki, A. (2003) · Development · doi:10.1242/dev.00615 · Cited by 76
RFWD3–Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage
Fu, X., Yucer, N., Liu, S., Li, M., Yi, P., Mu, J.-J., Yang, T., Chu, J., Jung, S. Y., O’Malley, B. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912094107 · Cited by 82
“Mdm2 is the major p53 E3 ligase, because embryonic lethality of Mdm2-knockout mice caused by p53-induced apoptosis is rescued by deletion of p53 (8, 9).”
BackgroundWilkinson, D. S., Ogden, S. K., Stratton, S. A., Piechan, J. L., Nguyen, T. T., Smulian, G. A., & Barton, M. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1200-1212.2005 · Cited by 76
“Mice null for the TRP53 gene appear developmentally normal; however, further studies show that p53 levels are tightly and critically regulated during embryogenesis (39, 53).”
BackgroundWhat have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 76
Self-citationGenealogy, expression, and molecular mechanisms in apoptosis
Dlamini, Z., Mbita, Z., & Zungu, M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.005 · Cited by 84
Convergence of p53 and TGF-beta signaling networks
Dupont, S., Zacchigna, L., Adorno, M., Soligo, S., Volpin, D., Piccolo, S., & Cordenonsi, M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.008 · Cited by 82
30 years and a long way into p53 research
Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 87
Ubiquitous Induction of p53 in Tumor Cells by Antisense Inhibition of MDM2 Expression
Chen, L., Lu, W., Agrawal, S., Zhou, W., Zhang, R., & Chen, J. (1999) · Molecular Medicine · doi:10.1007/bf03402136 · Cited by 79
“Experiments using MDM2 knockout mice confirmed that an important function of MDM2 is to negatively regulate p53 (14,15).”
BackgroundThe ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
Liu, J., Zhang, C., Xu, D., Zhang, T., Chang, C., Wang, J., Liu, J., Zhang, L., Haffty, B. G., Zong, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164354 · Cited by 80
“MDM2 KO in mice resulted in embryonic lethality due to uncontrolled wtp53 accumulation and activation and the resultant wtp53-mediated apoptosis, which can be rescued by p53 KO in mice (57).”
BackgroundDNA double-strand breaks: A potential causative factor for mammalian aging?
Li, H., Mitchell, J. R., & Hasty, P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.002 · Cited by 83
The p53 tumor suppressor: Critical regulator of life & death in cancer
Fisher, D. E. (2001) · APOPTOSIS · doi:10.1023/a:1009659708549 · Cited by 86
Spatio-temporal modelling of the Hes1 and p53-Mdm2 intracellular signalling pathways
Sturrock, M., Terry, A. J., Xirodimas, D. P., Thompson, A. M., & Chaplain, M. A. J. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.12.016 · Cited by 74
Chávez‐Reyes, A., Parant, J. M., Amelse, L. L., Luna, R. M. D. O., Korsmeyer, S. J., & Lozano, G. (2003) · PubMed · Cited by 89
Self-citationRegulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
Cheng, Q., Cross, B., Li, B., Chen, L., Li, Z., & Chen, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05553-11 · Cited by 73
“Current evidence suggests that MDM2 is a major and indispensable regulator of p53 level (18, 32).”
BackgroundStructural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Nomura, K., Klejnot, M., Kowalczyk, D., Hock, A. K., Sibbet, G. J., Vousden, K. H., & Huang, D. T. C. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3414 · Cited by 76
Targeting the MDM2-p53 protein–protein interaction for new cancer therapeutics
Wang, S., Zhao, Y., Bernard, D., Aguilar, A., & Kumar, S. (2012) · Topics in Medicinal Chemistry · doi:10.1007/978-3-642-28965-1_2 · Cited by 72
“The physiological relevance of this regulatory loop was demonstrated by the genetic evidence that embryonic lethality of Mdm2-null mice can be successfully rescued by the simultaneous deletion of the p53 gene [16, 17].”
BackgroundNguyen, D. T. T., Richter, D., Michel, G., Mitschka, S., Kolanus, W., Cuevas, E., & Wulczyn, F. G. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.54 · Cited by 71
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Slatter, T. L., Hung, N. A., Campbell, H. G., Rubio, C., Mehta, R., Renshaw, P., Williams, G., Wilson, M., Engelmann, A., Jeffs, A. R., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321851 · Cited by 90
Kallen, J., Goepfert, A., Blechschmidt, A., Izaac, A., Geiser, M., Tavares, G., Ramage, P., Furet, P., Masuya, K., & Lisztwan, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809096200 · Cited by 71
DNA damage, p14ARF, Nucleophosmin (NPM/B23), and cancer
Gjerset, R. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9040-y · Cited by 87
Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7
Zhao, K., Yang, Y., Zhang, G., Wang, C., Wang, D., Wu, M., & Mei, Y. (2018) · EMBO Reports · doi:10.15252/embr.201744465 · Cited by 77
“The principle ubiquitin E3 ligase for p53 is Mdm2 [11–13], the importance of which is underscored by the findings that Mdm2 deficiency-caused early embryonic lethality in mice can be completely rescued by the concomitant deletion of p53 [14,15].”
DNA repair during organogenesis
Vinson, R. K., & Hales, B. F. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00223-3 · Cited by 83
p53: at the crossroad between cancer and ageing
Papazoglu, C., & Mills, A. (2007) · The Journal of Pathology · doi:10.1002/path.2086 · Cited by 72
“This was elegantly demonstrated by the finding that Mdm2-deficient mice are embryonic lethal and by the fact that p53 deficiency genetically rescues this lethality [51,52].”
BackgroundAn analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function
Thomas, A., & White, E. (1998) · Genes & Development · doi:10.1101/gad.12.13.1975 · Cited by 72
“Loss of Mdm2 resulted in early embryonic lethality, which was rescued by deletion of p53 (Donehower et al. 1992; Montes de Oca Luna et al. 1995).”
BackgroundYi, H., Yan, X., Luo, Q., Yuan, L., Li, B., Pan, W., Zhang, L., Chen, H., Wang, J., Zhang, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0765-8 · Cited by 71
Loss of Mdm4 Results in p53 -Dependent Dilated Cardiomyopathy
Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Fernandez-Garcia, B., & Lozano, G. (2007) · Circulation · doi:10.1161/circulationaha.107.689901 · Cited by 71
Self-citationInactivation of the tumor suppressor p53 by long noncoding RNA RMRP
Chen, Y., Hao, Q., Wang, S., Cao, M., Huang, Y., Weng, X., Wang, J., Zhang, Z., He, X., Lu, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026813118 · Cited by 71
“Genetic studies showed that depletion of the p53 gene completely rescues embryonic lethality of Mdm2-knockout mice, gracefully validating the central role of MDM2 in the control of p53 activity (12, 13).”
BackgroundThe p53 mutation “gradient effect” and its clinical implications
Zambetti, G. P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21217 · Cited by 71
MEK-ERK-mediated Phosphorylation of Mdm2 at Ser-166 in Hepatocytes
Malmlöf, M., Roudier, E. A., Högberg, J., & Stenius, U. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604953200 · Cited by 85
Metadata
- Authors
- de Oca Luna, R. M., Wagner, D. S., & Lozano, G.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Nature
- Published
- 1995-11
- Volume
- 378
- Issue
- 6553
- Pages
- 203-206
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969044026
- Semantic Scholar
- e682601f6b2b8de8fa63cc39518a1461943483bc
- Cited by
- 1,420
- References
- 29
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 31 · 2023: 30 · 2022: 31 · 2021: 32 · 2020: 49 · 2019: 29 · 2018: 32 · 2017: 49 · 2016: 63 · 2015: 44 · 2014: 67 · 2013: 37 · 2012: 63
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, embryonic lethality, p53-MDM2 interaction, tumor suppressor, sarcoma, homologous recombination, DNA repair
- MeSH terms
- Animals, Base Sequence, Cell Line, Crosses, Genetic, Female, Genes, Lethal, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Tumor Suppressor Protein p53, Gene Deletion, DNA Primers, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.